Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recognition and Regulation of T Cells by NK Cells
Katharina Pallmer, Annette Oxenius
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Natural Killer Cells: Development, Maturation, and Clinical Utilization
Alex M. Abel, Chao Yang, Monica S. Thakar, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 935
Natural killer cells and other innate lymphoid cells in cancer
Laura Chiossone, Pierre‐Yves Dumas, Margaux Vienne, et al.
Nature reviews. Immunology (2018) Vol. 18, Iss. 11, pp. 671-688
Closed Access | Times Cited: 856
NK Cell-Based Immune Checkpoint Inhibition
Muhammad Khan, Sumbal Arooj, Hua Wang
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 276
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
Jing He, Ruijun Zhang, Miao Shao, et al.
Annals of the Rheumatic Diseases (2019) Vol. 79, Iss. 1, pp. 141-149
Open Access | Times Cited: 269
The Role of Natural Killer Cells in Autoimmune Diseases
Umut Can Küçüksezer, Esin Aktaş Çetin, Fehim Esen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 177
TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer
Zhouhong Ge, Maikel P. Peppelenbosch, Dave Sprengers, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 160
Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS)
Veronika Ehrlich, Wieneke Bil, Rob J. Vandebriel, et al.
Environmental Health (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 123
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing
Sumin Jo, Shipra Das, Alan F. Williams, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 95
Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults
Sathyabaarathi Ravichandran, Fernando Erra Díaz, Emin Onur Karakaslar, et al.
Nature Immunology (2024) Vol. 25, Iss. 2, pp. 316-329
Open Access | Times Cited: 15
NKG2A is a NK cell exhaustion checkpoint for HCV persistence
Chao Zhang, Xiaomei Wang, Shu-ran Li, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 130
Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans
Wivine Burny, Andrea Callegaro, Viviane Bechtold, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 126
Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells
Michelle Sætersmoen, Quirin Hammer, Bahram Valamehr, et al.
Seminars in Immunopathology (2018) Vol. 41, Iss. 1, pp. 59-68
Closed Access | Times Cited: 125
Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells
Mattias Carlsten, Marcus Järås
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 124
Lactobacillus plantarum DR7 improved upper respiratory tract infections via enhancing immune and inflammatory parameters: A randomized, double-blind, placebo-controlled study
Hui-Xian Chong, Nur Asmaa’ A. Yusoff, Yan-Yan Hor, et al.
Journal of Dairy Science (2019) Vol. 102, Iss. 6, pp. 4783-4797
Open Access | Times Cited: 107
CD8+ T Lymphocyte and NK Cell Network: Circuitry in the Cytotoxic Domain of Immunity
Roman V. Uzhachenko, Anil Shanker
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 103
Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients
Hansol Lee, Camelia Quek, Inês Pires da Silva, et al.
OncoImmunology (2018) Vol. 8, Iss. 2, pp. e1537581-e1537581
Open Access | Times Cited: 95
Directing Traffic: How to Effectively Drive T Cells into Tumors
Annabelle Anandappa, Catherine J. Wu, Patrick A. Ott
Cancer Discovery (2020) Vol. 10, Iss. 2, pp. 185-197
Open Access | Times Cited: 91
piggyBac system to co-express NKG2D CAR and IL-15 to augment the in vivo persistence and anti-AML activity of human peripheral blood NK cells
Zhicheng Du, Yu Yang Ng, Shijun Zha, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 23, pp. 582-596
Open Access | Times Cited: 58
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
McKenzie Crist, Benyamin Yaniv, Sarah Palackdharry, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 11, pp. e005632-e005632
Open Access | Times Cited: 47
The role of CD56bright NK cells in neurodegenerative disorders
Carla Rodriguez-Mogeda, Chaja M. J. van Ansenwoude, Lennart van der Molen, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 13
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance
Michael Kilian, Mirco Friedrich, K.H. Lu, et al.
Science Immunology (2024) Vol. 9, Iss. 95
Closed Access | Times Cited: 9
NKp44/HLA-DP-dependent regulation of CD8 effector T cells by NK cells
Benedetta Padoan, Christian Casar, Jenny Krause, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114089-114089
Open Access | Times Cited: 8
Allogeneic CAR T cell therapies for leukemia
Waseem Qasim
American Journal of Hematology (2019) Vol. 94, Iss. S1
Open Access | Times Cited: 67
Cytotoxic Immunity in Peripheral Nerve Injury and Pain
Alexander J. Davies, Simon Rinaldi, Michael Costigan, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 60
Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy
Silvia Gaggero, Kristina Witt, Mattias Carlsten, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top